The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
New Phase III data on gefurulimab highlight potential as a self-administered treatment option; real-world evidence reinforces clinical benefits of Ultomiris and Soliris
Subscribe To Our Newsletter & Stay Updated
